Phreesia (PHR) Analyst Model Updated to Reflect Company’s Latest Financial Guidance for 2026-2027

Group 1 - Phreesia Inc. is projected to double in value by 2026, with Baird lowering its price target from $31 to $25 while maintaining an Outperform rating [1] - In FQ3 2026, Phreesia reported total revenue of $120.3 million, a 13% year-over-year increase, and achieved a net income of $4.3 million for the second consecutive quarter [2] - The number of Average Healthcare Services Clients (AHSCs) reached 4,520, reflecting a 53% increase from the previous quarter, primarily due to the acquisition of AccessOne [2] Group 2 - Phreesia's FY2026 revenue outlook is adjusted to a range of $479 to $481 million, considering market fluidity and regulatory uncertainties, while FY2027 revenue is expected to be between $545 and $559 million [3] - The 2027 revenue guidance anticipates mid-single-digit growth in AHSCs and double-digit growth in revenue per AHSC, with network solutions expected to be the fastest-growing segment [3] - Phreesia provides an integrated SaaS-based software and payment platform for the healthcare industry in the US and Canada [4]